Feature | November 09, 2006 | Cristen C. Bolan

RSNA 2006 Stages the Changing Role of Radiology

As if RSNA wasn’t big enough, expect it to be even bigger this year. As the scope of radiology widens, so does the category of radiology subspecialties. RSNA 2006 has designed its program to reflect this change, adding to its curriculum important research across multiple radiology subspecialties – cardiac radiology, emergency radiology, neuroradiology, vascular and interventional radiology, breast/mammography, gastrointestinal radiology and genitourinary radiology, to name just a few. In light of molecular imaging’s tremendous potential for eradicating diseases — by revealing the early presence or likelihood of disease — molecular imaging will make its debut as a subspecialty area at this year’s RSNA.
Take note that the growing number of subspecialties is the precursor to the convergence of certain medical disciplines – principally radiology, pathology and cardiology – and manufacturers are poised to deliver new solutions for these anticipated developments.
Vendor participants at RSNA are also eager to show off their new product releases, many of which are inspired by growth areas in radiology, such as PET/CT and SPECT/CT hybrids, multislice CT, high channel MR, cardiac CT and MR, artificial intelligence and EMR/PACS solutions. Get a sneak peak at these in our extensive RSNA Preview in this issue.
The RSNA Scientific Program Committee is enthusiastic about this year’s presentations, which will introduce new approaches to fusion, perfusion/diffusion, multiplanar and dual energy imaging techniques, advancements in multislice CT, the explosion of cardiac CT, as well as novel CAD applications.
Imaging Technology News is looking forward to hitting the RSNA floor and seeing new technology in action. But we are especially interested in meeting our readers in person. So please stop by to see us at Booth #3915, or e-mail me to arrange a meeting in advance, [email protected].
See you at the show!

Related Content

Researchers Trace Parkinson’s Damage in the Heart
News | PET Imaging | July 17, 2018
A new way to examine stress and inflammation in the heart will help Parkinson’s researchers test new therapies and...
Siemens Healthineers Announces FDA Clearance of syngo.via VB30 Molecular Imaging Software
Technology | Nuclear Imaging | July 16, 2018
At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26 in Philadelphia...
SNMMI Image of the Year Highlights Theranostic Approach for Advanced Prostate Cancer

IMAGE OF THE YEAR: PSMA PET before and after lutetium-177 PSMA617 theranostics in 8 patients with metastatic prostate cancer who exhausted standard therapeutic options.

68Ga-PSMA11 PET maximum intensity projection (MIP) images at baseline and 3 months after 177Lu-PSMA617 in 8 patients with PSA decline ≥ 98 percent in a prospective phase II study. Any disease with SUV over 3 is in red. Credit: Michael Hofman, John Violet, Shahneen Sandhu, Justin Ferdinandus, Amir Iravani, Grace Kong, Aravind Ravi Kumar, Tim Akhurst, Sue Ping Thang, Price Jackson, Mark Scalzo, Scott Williams and Rodney Hicks, Peter MacCallum Cancer Centre, Melbourne, Australia.

News | PET Imaging | June 29, 2018
In the battle against metastatic castrate-resistant prostate cancer, studies have demonstrated a high response rate to...
MILabs Introduces Futuristic PET Capabilities on New VECTor6 System
Technology | PET Imaging | June 28, 2018
At the 2018 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, June 23-26, in Philadelphia,...
Philips North America and GE Healthcare Win IMV PET Imaging ServiceTrak Awards
News | PET Imaging | June 25, 2018
IMV, part of the Science and Medicine Group and a market research and business intelligence provider to the imaging...
New ASNC SPECT Imaging Guideline Addresses Advances in Myocardial Perfusion Imaging
News | SPECT Imaging | June 21, 2018
The American Society of Nuclear Cardiology (ASNC) has published an update to its 2010 guidelines for single photon...
FDA Clears New Imaging Functionalities for Biograph mCT PET/CT Systems
Technology | PET-CT | June 21, 2018
Siemens Healthineers will announce U.S. Food and Drug Administration (FDA) clearance of four new system features for...
PET/CT Changes Care for 59 Percent of Suspected Recurrent Prostate Cancer Cases
News | Prostate Cancer | June 13, 2018
A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine positron emission...
Nuclear imaging scan showing very good tissue delineation. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Nuclear imaging scan showing very good tissue delineation. It offers crisp overall image quality and sharply delineates the muscle and fat planes, vertebral margins and end plates, billiary radicals, renal calyces, aortic wall and papillary muscles of the heart. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Technology | PET-CT | June 05, 2018
June 5, 2018 — The U.S.
Overlay Init